Monopar Therapeutics Inc
F:1IY0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Monopar Therapeutics Inc
F:1IY0
|
US |
|
F
|
Flex Ltd
SWB:FXI
|
SG |
|
K
|
Kawasaki Kisen Kaisha Ltd
OTC:KAIKY
|
JP |
|
F
|
Fluor Corp
XBER:FLU
|
US |
|
Y
|
Yext Inc
F:0YE
|
US |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
|
D
|
Digital Realty Trust Inc
F:FQI
|
US |
|
B
|
British American Tobacco PLC
OTC:BTAFF
|
UK |
|
Marubeni Corp
F:MAR0
|
JP |
|
N
|
Novartis AG
XMUN:NOT
|
CH |
|
H
|
Hartford Financial Services Group Inc
SWB:HFF
|
US |
|
C
|
Canadian Imperial Bank of Commerce
NYSE:CM
|
CA |
|
F
|
FirstEnergy Corp
LSE:0IPB
|
US |
|
B
|
Barratt Developments P L C
XBER:3BA
|
UK |
|
Construction Partners Inc
NASDAQ:ROAD
|
US |
|
Bandai Namco Holdings Inc
OTC:NCBDF
|
JP |
|
D
|
DaVita Inc
XBER:TRL
|
US |
|
A
|
argenx SE
SWB:1AEA
|
NL |
|
D
|
Daimler AG
XHAM:DAI
|
DE |
|
A
|
Airbus SE
F:AIR
|
NL |
|
Pharvaris NV
F:9EN
|
NL |
|
F
|
Fresenius SE & Co KGaA
XBER:FRE
|
DE |
|
F
|
FedEx Corp
BMV:FDX
|
US |
|
Abb Ltd
OTC:ABBNY
|
CH |
Bankruptcy Probability
Monopar Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Monopar Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
586.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
429.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Monopar Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Monopar Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
